Get Started
Home > Blog > Weight Loss

GLP-1 Weight Loss Medications: Tirzepatide vs Semaglutide Complete Guide (2025)

Updated February 2025 • 8 min read
Quick Answer: Which GLP-1 Medication Is Best for Weight Loss?

Clinical trials show Tirzepatide achieves 15-22.5% body weight reduction, while Semaglutide delivers 15-17% weight loss. Tirzepatide targets both GIP and GLP-1 receptors, potentially offering superior results. Both medications require physician supervision and work best combined with lifestyle changes.

Understanding GLP-1 Weight Loss Medications

GLP-1 (Glucagon-Like Peptide-1) receptor agonists represent the most significant breakthrough in medical weight management in decades. Originally developed for type 2 diabetes treatment, these medications have demonstrated unprecedented effectiveness for weight loss in clinical trials.

These medications work by mimicking natural hormones that regulate appetite, slow gastric emptying, and improve metabolic function. The result is reduced hunger, increased satiety, and substantial weight reduction that was previously achievable only through bariatric surgery.

15-22% Average Weight Loss
68-72 Weeks to Full Effect
1.5-2.4 mg Typical Dose
Weekly Injection Frequency

Tirzepatide vs Semaglutide: Head-to-Head Comparison

Feature Tirzepatide Semaglutide
Brand Names Mounjaro, Zepbound Ozempic, Wegovy
Mechanism Dual GIP/GLP-1 agonist GLP-1 agonist only
Average Weight Loss 15-22.5% 15-17%
FDA Approved for Weight Yes (Zepbound) Yes (Wegovy)
Typical Monthly Cost $299-500+ $299-400+
Common Side Effects Nausea, diarrhea, vomiting Nausea, diarrhea, constipation

How Tirzepatide Works

Tirzepatide is a dual incretin agonist that targets both GIP (Glucose-Dependent Insulinotropic Polypeptide) and GLP-1 receptors. This dual mechanism may explain its superior weight loss results in clinical trials. The SURMOUNT-1 study published in the New England Journal of Medicine demonstrated that participants lost up to 22.5% of their body weight over 72 weeks.

How Semaglutide Works

Semaglutide selectively targets GLP-1 receptors, suppressing appetite and slowing gastric emptying. The STEP trials showed consistent 15-17% weight reduction, with many participants achieving clinically meaningful weight loss of 10% or more within the first 16 weeks.

Expected Weight Loss Timeline

Both medications follow a similar progression pattern, though individual results vary based on starting weight, adherence to treatment, and lifestyle factors:

  • Weeks 1-4: Initial dose titration, minimal weight change as body adjusts
  • Weeks 5-12: Gradual dose increases, 2-5% weight loss typically observed
  • Weeks 13-24: Therapeutic dosing begins, 8-12% weight loss common
  • Weeks 25-52: Continued progression toward maximum results
  • Week 52+: Weight stabilization at 15-22% reduction

Research indicates that patients who combine GLP-1 medications with dietary modifications and increased physical activity achieve 23% greater weight loss than medication alone.

Side Effects and Safety Considerations

Gastrointestinal symptoms are the most commonly reported side effects, affecting 40-70% of users during the initial titration phase. These typically resolve within 2-4 weeks as the body adapts.

Common Side Effects

  • Nausea (occurs in 44% of patients initially)
  • Diarrhea (30%)
  • Vomiting (25%)
  • Constipation (24%)
  • Abdominal pain (20%)

Who Should Not Use GLP-1 Medications

These medications are contraindicated for individuals with:

  • Personal or family history of medullary thyroid carcinoma
  • Multiple Endocrine Neoplasia syndrome type 2
  • Previous severe allergic reaction to GLP-1 agonists
  • Pregnancy or breastfeeding
  • History of pancreatitis

Accessing GLP-1 Medications Online

Telehealth platforms have revolutionized access to weight loss medications, eliminating traditional barriers like requiring an in-person doctor visit or dealing with insurance prior authorizations.

Online Process Overview

  1. Complete health questionnaire and medical history
  2. Licensed physician reviews your information (typically within 24 hours)
  3. If approved, receive personalized treatment plan
  4. Medication shipped directly to your door
  5. Ongoing support and dose adjustments as needed

This approach offers significant advantages: no waiting weeks for appointments, transparent pricing without insurance complications, discreet home delivery, and continuous medical oversight throughout your weight loss journey.

Ready to Start Your Weight Loss Journey?

Access physician-supervised Tirzepatide and Semaglutide online. No prescription required. Results in as little as 4 weeks.

Get Started with Enhance.md

Frequently Asked Questions

Do I need a prescription to get these medications online?
No prior prescription is needed. Telehealth platforms connect you with licensed physicians who evaluate your medical history and provide prescriptions if appropriate. The entire process is completed online without visiting a doctor's office.
How much weight will I actually lose?
Clinical trials show average weight loss of 15-22% for Tirzepatide and 15-17% for Semaglutide over 12-18 months. Individual results vary based on starting weight, medication adherence, and lifestyle factors. Most patients see noticeable results within 4-8 weeks.
Are compounded versions as effective as brand names?
Compounded medications contain the same active ingredients (Semaglutide or Tirzepatide) as brand-name products. When sourced from accredited compounding pharmacies, they work identically in the body. The primary difference is typically cost, with compounded versions often being more affordable.
What happens when I stop taking the medication?
Studies show that stopping GLP-1 medications typically results in regaining 50-70% of lost weight within 12 months. Long-term maintenance may require ongoing treatment or intensive lifestyle intervention. Your physician can help develop a maintenance strategy.
Affiliate Disclosure: This guide contains affiliate links to Enhance.md. We may earn a commission if you make a purchase through our links at no additional cost to you. Our recommendations are based on thorough research and genuine value to readers, not commission rates. Always consult with a healthcare provider before starting any weight loss medication.

Key Takeaways

  • GLP-1 medications represent the most effective non-surgical weight loss treatment available, with clinical evidence supporting 15-22% body weight reduction
  • Tirzepatide's dual mechanism may offer superior results compared to Semaglutide, though both are highly effective
  • Online telehealth platforms have made these medications accessible without traditional barriers
  • Side effects are typically mild and transient, resolving within the first month
  • Long-term success requires commitment to lifestyle changes alongside medication
  • Medical supervision is essential for safe, effective treatment